Skip navigation

6th Annual Pharma/Biotech Device Corporate Tax Congress

Covering the Latest Tax and Transfer Pricing Matters Impacting Health Science Companies

November 14-15, 2011
  • Philadelphia, Pennsylvania

Pharmaceutical Tax Opportunities and Challenges Addressed\

CBI’s pharmaceutical tax conference tackles the most timely and relevant corporate tax matters impacting life science companies. Through a series of executive presentations, closed-door forums and industry-only dialogue, pharmaceutical and biotechnology corporate tax and transfer pricing professionals gain a comprehensive update on legislative developments, IRS rulings and tax planning opportunities at the CBI forum.

Healthcare reform, the advent of industry fees, legislative developments impacting corporate tax and an active IRS enforcement environment have created unprecedented complexities and challenges for life sciences corporate tax professionals. Attend this meeting to network with your peers and counterparts in the industry and to keep current on the latest issues impacting pharmaceutical and biotechnology tax and transfer pricing planning.



In-Depth Coverage and Closed-Door Sessions On:

•  Federal Legislation

•  Territorial Income

•  Industry Fees

•  Transfer Pricing

•  Supply Chain Tax Planning

•  Implications of UTP Disclosur

•  Codification of “Economic Substance”

•  R&D Credits

•  IRS Transfer Pricing Audits


Co-Sponsored by: Deloitte

Deloitte serves the life sciences industry through a cross-functional health sciences team of more than 3,000 highly skilled professionals. As part of one of the world’s largest tax practices, our practitioners have diverse experience across the industry, including pharmaceuticals, biotechnology and medical technology and devices. We provide tax planning, tax consulting, compliance and other specialized support services to leading companies across the value chain, including suppliers, manufacturers, distributors and retailers. As a leading business advisor to the life sciences industry, Deloitte’s mission is to work with our clients to shape the evolution of life sciences. Our national life sciences practice brings more than 70 years of industry experience, delivering a range of audit, tax, consulting and financial advisory services to many facets of the industry. For more information about our life sciences tax practice, please visit our website at or


Gold Sponsor: PwC

PwC’s Pharmaceutical and Life Sciences Industry Group (
or is dedicated to delivering effective solutions to the complex strategic, operational and financial challenges facing pharmaceutical, biotechnology and medical device companies. We provide industry-focused assurance, tax and advisory services to build public trust and enhance value for our clients and their stakeholders. More than 163,000 people in 151 countries across our network share their thinking, experience and solutions to develop fresh perspectives and practical advice.